Low adherence to guidelines in non-muscle-invasive disease

被引:43
作者
van Rhijn, Bas W. G. [1 ,2 ]
Burger, Maximilian [2 ]
机构
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol Urol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[2] Univ Regensburg, Caritas St Josef Med Ctr, Dept Urol, Landshuterstr 65, D-93053 Regensburg, Germany
关键词
BLADDER-CANCER; THERAPY;
D O I
10.1038/nrurol.2016.165
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The American Urological Association, the Society of Urologic Oncology and the European Association of Urology have recently updated their guidelines for diagnosis and treatment of non-muscle-invasive bladder cancer. Several studies show that adherence to these guidelines is low, especially in North America. Physicians should try to comply with these guidelines to ensure optimal quality of care.
引用
收藏
页码:570 / 571
页数:2
相关论文
共 10 条
[1]  
[Anonymous], EUR UROL
[2]  
[Anonymous], J UROL
[3]   Compliance with guidelines for patients with bladder cancer [J].
Chamie, Karim ;
Saigal, Christopher S. ;
Lai, Julie ;
Hanley, Jan M. ;
Setodji, Claude M. ;
Konety, Badrinath R. ;
Litwin, Mark S. .
CANCER, 2011, 117 (23) :5392-5401
[4]   Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian Study [J].
Gontero, Paolo ;
Oderda, Marco ;
Altieri, Vincenzo ;
Bartoletti, Riccardo ;
Cai, Tommaso ;
Colombo, Renzo ;
Curotto, Antonio ;
Di Stasi, Savino ;
Maffezzini, Massimo ;
Tamagno, Stefania ;
Serretta, Vincenzo ;
Sogni, Filippo ;
Terrone, Carlo ;
Tizzani, Alessandro ;
Morgia, Giuseppe ;
Mirone, Vincenzo ;
Carmignani, Giorgio .
UROLOGIA INTERNATIONALIS, 2011, 86 (01) :19-24
[5]   Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta [J].
Gotto, Geoffrey T. ;
Shea-Budgell, Melissa A. ;
Ruether, J. Dean .
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2016, 10 (1-2) :33-38
[6]   Predictors of intravesical therapy for nonmuscle invasive bladder cancer: Results from the Surveillance, Epidemiology and End Results Program 2003 Patterns of Care Project [J].
Huang, George J. ;
Hamilton, Ann S. ;
Lo, Mary ;
Stein, John P. ;
Penson, David F. .
JOURNAL OF UROLOGY, 2008, 180 (02) :520-524
[7]   Treatment of Nonmuscle Invading Bladder Cancer: Do Physicians in the United States Practice Evidence Based Medicine? The Use and Economic Implications of Intravesical Chemotherapy After Transurethral Resection of Bladder Tumors [J].
Madeb, Ralph ;
Golijanin, Dragan ;
Noyes, Katia ;
Fisher, Susan ;
Stephenson, Judith J. ;
Long, Stacey R. ;
Knopf, Joy ;
Lyman, Gary H. ;
Messing, Edward M. .
CANCER, 2009, 115 (12) :2660-2670
[8]   Versorgungsstandard bei neu diagnostiziertem BlasenkarzinomEine prospektive Erhebung in NorddeutschlandQuality of care in patients with newly diagnosed bladder cancerA prospective assessment in northern Germany [J].
C. Reek ;
M. Rink ;
M. Bloch ;
J. Hansen ;
F.K. Chun ;
A. Schneider ;
J. Busche ;
M. Fisch .
Der Urologe, 2013, 52 (7) :986-990
[9]   Challenges in non-muscle invasive bladder cancer: lessons from a regional review [J].
Siddins, Mark T. ;
Wong, Vun Vun ;
Fitzgerald, Jude Thomas ;
Bamberg, Lisa Jane .
ANZ JOURNAL OF SURGERY, 2011, 81 (12) :889-894
[10]   Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guerin (BCG): results of an international individual patient data survey (IPDS) [J].
Witjes, J. Alfred ;
Palou, Joan ;
Soloway, Mark ;
Lamm, Donald ;
Kamat, Ashish M. ;
Brausi, Maurizio ;
Persad, Raj ;
Buckley, Roger ;
Colombel, Marc ;
Boehle, Andreas .
BJU INTERNATIONAL, 2013, 112 (06) :742-750